Net Cash Provided by (Used in) Financing Activities of PAVmed Inc. from 31 Dec 2017 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
PAVmed Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2017 to 31 Mar 2025.
  • PAVmed Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $3,102,000, a 84% decline year-over-year.
  • PAVmed Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $31,284,000, a 0.36% increase from 2023.
  • PAVmed Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $31,173,000, a 18% decline from 2022.
  • PAVmed Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $38,211,000, a 63% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

PAVmed Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,102,000 -$15,946,000 -84% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $19,048,000 -$5,876,000 -24% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $24,924,000 +$24,608,000 +7787% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $316,000 -$40,178,000 -99% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $40,494,000 +$34,189,000 +542% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $6,305,000 +$6,464,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $159,000 -$4,454,573 -104% 01 Jan 2019 31 Mar 2019 10-Q 28 May 2020 2020 Q1
Q1 2018 $4,295,573 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1

PAVmed Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $31,284,000 +$111,000 +0.36% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $31,173,000 -$7,038,000 -18% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $38,211,000 -$66,098,000 -63% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2024 2023 FY
2021 $104,309,000 +$71,303,000 +216% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023 2022 FY
2020 $33,006,000 +$21,625,000 +190% 01 Jan 2020 31 Dec 2020 10-K 06 Apr 2022 2021 FY
2019 $11,381,000 -$4,120,613 -27% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021 2020 FY
2018 $15,501,613 +$7,938,762 +105% 01 Jan 2018 31 Dec 2018 10-K 14 Apr 2020 2019 FY
2017 $7,562,851 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.